Australia - englanti - APVMA (Australian Pesticides and Veterinary Medicines Authority)

clark rubber franchising pty ltd - polyhexanide hydrochloride - aqueous concentrate - polyhexanide hydrochloride guanidine active 200.0 g/l - pool sanitiser - spa | swimming pool | outdoor spa | spa pools - bacteria | water treatment/sanitiser

Australia - englanti - APVMA (Australian Pesticides and Veterinary Medicines Authority)

clark rubber franchising pty ltd - copper present as a complex blend of copper salts; benzalkonium chloride - liquid - copper present as a complex blend of copper salts mineral-copper-salt active 19.0 g/l; benzalkonium chloride ammonium-quaternary active 100.0 g/l - pool algicide - swimming pool - black algae | blue-green algae - phormidium spp. | mustard algae | bluegreen algae | filamentous blue-green algae

Australia - englanti - APVMA (Australian Pesticides and Veterinary Medicines Authority)

clark rubber franchising pty ltd - chlorine present as trichloroisocyanuric acid - tablet (inc. pellet, bolus, suppository, capsule) - chlorine present as trichloroisocyanuric acid mineral-chlorine-acid active 900.0 g/kg - pool chlorine - swimming pool - outdoor - algae | bacteria

Australia - englanti - APVMA (Australian Pesticides and Veterinary Medicines Authority)

clark rubber franchising pty ltd - chlorine present as trichloroisocyanuric acid; copper present as copper sulfate pentahydrate - tablet (inc. pellet, bolus, suppository, capsule) - chlorine present as trichloroisocyanuric acid mineral-chlorine-acid active 810.0 g/kg; copper present as copper sulfate pentahydrate mineral-copper active 7.5 g/kg - pool chlorine - swimming pool - outdoor - algae | bacteria

Australia - englanti - APVMA (Australian Pesticides and Veterinary Medicines Authority)

clark rubber franchising pty ltd - chlorine present as calcium hypochlorite - granular formulation - chlorine present as calcium hypochlorite mineral-chlorine active 700.0 g/kg - pool chlorine - swimming pool - algae | bacteria

Australia - englanti - APVMA (Australian Pesticides and Veterinary Medicines Authority)

clark rubber franchising pty ltd - bromine; chlorine present as bromo-chloro-dimethylhydantoin - tablet (inc. pellet, bolus, suppository, capsule) - bromine mineral-bromine active 650.0 g/kg; chlorine present as bromo-chloro-dimethylhydantoin mineral-chlorine active 280.0 g/kg - pool algicide - hot tub | spa | swimming pool | outdoor spa | spa | spa pools - algae | bacteria

Australia - englanti - APVMA (Australian Pesticides and Veterinary Medicines Authority)

clark rubber franchising pty ltd - chlorine present as sodium dichloroisocyanurate - granular formulation - chlorine present as sodium dichloroisocyanurate mineral-chlorine active 560.0 g/kg - algicide - swimming pool - outdoor - algae | bacteria

Australia - englanti - APVMA (Australian Pesticides and Veterinary Medicines Authority)

clark rubber franchising pty ltd - sodium bromide; chlorine present as sodium dichloroisocyanurate - granular formulation - sodium bromide mineral-bromide active 150.0 g/kg; chlorine present as sodium dichloroisocyanurate mineral-chlorine active 510.0 g/kg - pool chlorine - spa | outdoor spa | spa pools - algae | bacteria

Australia - englanti - APVMA (Australian Pesticides and Veterinary Medicines Authority)

clark rubber franchising pty ltd - chlorine present as lithium hypochlorite - granular formulation - chlorine present as lithium hypochlorite mineral-chlorine active 350.0 g/kg - pool chlorine - spa | outdoor spa | spa pools - algae | bacteria

Yhdysvallat - englanti - NLM (National Library of Medicine)

larken laboratories, inc. - dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - dexamethasone 1.5 mg - allergic states: control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, and serum sickness. dermatologic diseases: bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, and severe erythema multiforme (stevens-johnson syndrome). endocrine disorders: primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; may be used in conjunction with synthetic mineralocorticoid analogs where applicable; in infancy mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with cancer, and nonsuppurative thyroiditis. gastrointestinal diseases: to tide the patient over a critical period of the disease in regional enteritis and ulcerative colitis. hematologic disorders: acquired (autoimmune) hemolytic a